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ABSTRACT 
Background:  Prompt diagnosis of central nervous system (CNS) disease is critical to guide 
intervention and appropriate therapy.  Development of novel laboratory approaches to rapidly classify 
acute-onset CNS disease is in great demand.  Serious microbial pathogens, especially viruses, are 
quickly expanding beyond their historic geographic range and may not even be considered in the 
clinician’s differential diagnosis.  Unlike bacterial cultures, current viral testing targets a limited 
number of viruses.  Additionally, despite diversity in etiology, signs and symptoms of both infectious 
and non-infectious CNS disorders can be remarkably similar, which can confuse the clinical picture 
and delay treatment. Bacterial, viral, fungal and protozoan CNS pathogens are sensed by pattern 
recognition receptors of the immune system, stimulating immediate release of measurable levels of 
chemokines and cytokines into the CSF.  Our objective is to use pathogen-specific chemokine/
cytokine profiles to classify CNS disease as infectious versus non-infectious and further discriminate 
between viral and non-viral infections.  
Methods:  Levels (pg/ml) of chemokines and cytokines were determined in the CSF of 45 patients 
with documented infectious meningitis or meningoencephalitis (mean age 19.2 years) and in the CSF 
of 25 patients who were negative for CNS infection (mean age 27.4 years).  MILLIPLEX MAP Human 
Cytokine/Chemokine Magnetic Bead Panels (Millipore) were used to measure CSF chemokines and 
cytokines levels (pg/ml).  Innate immune analytes quantified included IP-10 (CXCL10), IFNg, IL-15, 
MDC (CCL22), MCP-1 (CCL2), Fractalkine, and FLT3L.  Samples were analyzed in duplicate by a 
FlexMAP 3D (Luminex).  Standard curves were generated for each cytokine and median fluorescent 
intensities were transformed into concentrations by 5-point, non-linear regression. For univariate 
analysis, comparisons between groups were made using the Mann-Whitney test.  We utilized receiver 
operating characteristic (ROC) curve analysis to calculate areas under the ROC curve (AUC) for each 
analyte to access the utility of chemokine/cytokine levels as discriminating tests.  The ROC generated 
sensitivity and specificity values were then used to determine clinically optimal cutoff values for the 
informative analytes. 
Results: Univariate analysis utilizing Mann-Whitney tests demonstrated that median values (pg/ml) 
of  IP-10 (CXCL10), IFNg, IL-15, MDC (CCL22), MDC (CCL22), MCP-1 (CCL2), Fractalkine, and 
FLT3L were all significantly higher in CSF from patients with infectious brain disorders than in CSF 
from patients with non-infectious disorders (p-value < 0.05).  MDC (CCL22) demonstrated statistical 
significance, when comparing viral infections versus non-viral infections (with the non-viral infection 
group having higher analyte levels).  IP10 (CXCL10) can reliably distinguish between an infectious 
versus non-infectious CNS process (AUC 0.9778) with an optimal cut-off value of 2023 pg/ml 
(sensitivity, specificity; 93.0%, 92.0%).  In the infectious group, MDC (CCL22) can reliably 
differentiate between viral and non-viral CNS infection (AUC 0.9545) with an optimal cut-off value of 
194 pg/ml (sensitivity, specificity; 91.67%, 87.88%).    
Conclusion:  CSF levels (pg/ml) of IP-10 (CXCL10) can reliably distinguish infectious versus non-
infectious CNS disorders, and in the infectious group, MDC (CCL22) can reliably distinguish between 
viral and non-viral CNS infections.  These results suggest that CSF chemokine/cytokine quantification 
can serve as a useful laboratory tool for the rapid triage of CNS diseases to help guide prompt therapy 
and further testing. 
 
RESULTS: PRINCIPAL COMPONENT ANALYSIS (PCA) 
Principal Component Analysis (PCA) with the variables IP10, IL15, MDC, FLT3L, 
and Fractalkine  
RESULTS: DESCRIPTIVE STATISTICS AND RECEIVER OPERATOR CURVES (ROC) 
CASE STUDY 
16 year old woman with 
history of lupus 
presented with CNS 
symptoms (ataxia with 
progression to altered 
mental status and 
paralysis).   
CSF studies were normal.  
CSF microbiology tests 
were negative.   
•  CSF levels (pg/ml) of IP-10/CXCL10 can reliably distinguish infectious 
versus non-infectious CNS disorders 
•  In the infectious group, MDC/CCL22 can reliably distinguish between 
viral and non-viral CNS infections.  
•  CSF chemokine/cytokine quantification can serve as a useful 
laboratory tool for the rapid triage of CNS diseases to help guide 
prompt therapy and further testing. 
Quantification of CSF chemokines and cytokines allows for rapid laboratory detection 
of CNS infections and further discrimination between viral and non-viral pathogens 
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BACKGROUND INFORMATION RESULTS: MANN-WHITNEY TEST OF SIGNIFICANCE 
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AUC = 0.9545 
AUC = 0.9778 
IP10/CXCL10 can reliably distinguish between an infectious (All I) versus non-
infectious (C+NI) CNS process (AUC 0.9778) with an optimal cut-off value of 2023 pg/ml 
(sensitivity, specificity; 93.0%, 92.0%).   
NON-­‐INFECTIOUS	  
CASES	  
INFECTIOUS	  CASES	  
HEADACHE,	  IDIOPATHIC	  
INTRACRANIAL	  
HYPERTENSION	  (IIH),	  
SUBARACHNOID	  
HEMORRHAGE,	  POSSIBLE	  
AUTOIMMUNE	  DISEASE	  
VIRAL:	  ENTEROVIRUS,	  HUMAN	  
PARECHOVIRUS,	  WEST	  NILE	  VIRUS,	  JC	  
VIRUS,	  HHV6	  
NON-­‐VIRAL:	  S.EPIDERMIDIS,	  
S.PNEUMONIAE,	  M.TUBERCULOSIS,	  
B.BURGDORFERI,	  TOXOPLASMOSIS,	  
CRYPTOCOCCUS	  NEOFORMANS	  
MDC LEVEL	   SENSITIVITY	   SPECIFICITY	   LIKELIHOOD RATIO	  
> 194.0	   91.67	   87.88	   7.563	  
> 238.3	   83.33	   87.88	   6.875	  
> 267.3	   83.33	   90.91	   9.167	  
> 355.9	   75.00	   90.91	   8.250	  
> 487.1	   66.67	   90.91	   7.333	  
> 556.6	   66.67	   93.94	   11.00	  
> 632.1	   66.67	   96.97	   22.00	  
> 884.2	   58.33	   96.97	   19.25	  
NON-INFECTIOUS VS 
INFECTIOUS	  
VIRAL VS  
NON-VIRAL	  
MCP1	   * (p=0.0494)	    	  
IFNγ	   ** (p=0.0035)	  
IP10	   **** (p<0.0001)	   NS 	  
IL15	   **** (p<0.0001)	   NS	  
MDC	   ** (p=0.0028)	   ****  (p<0.0001)	  
FLT3L	   ** (p=0.0057)	   NS	  
Fractalkine	   **** (p<0.0001)	   NS	  
Mann-Whitney tests of significance for 
non-parametric data 
 
Levels of all studied cytokines (MCP1, 
IFNγ, IP10, IL15, MDC, FLT3L, and 
Fractalkine) were significantly higher 
in the infectious compared to the non-
infectious group.  
IL15, Fractalkine, and FLT3L 
influence PC1.  
IP10 influences PC2. 
IL15, Fractalkine, FLT3L, 
and MDC influence PC1.  
IP10 influences PC3. 
CYTOKINE	   FUNCTION IN THE INFLAMMATORY RESPONSE	  
MCP1/CCL2 marker of non-specific inflammation	  
IP10/CXCL10 produced by a wide range of CNS cells in 
response to microbial pathogens; stimulated by 
multiple pathways	  
IL15 growth/survival factors for both NK cells and 
cytotoxic CD8+ T-cells	  
MDC/CCL22 produced in response to various microbial 
products; down-regulated by IFNγ	  
FLT3L supports maturation of antigen presenting cells 	  
FRACTALKINE/CX3CL1 support monocyte adhesion to endothelium	  
IFNγ major chemokine product of NK cells; 
stimulates phagocytosis and pathogen killing in 
macrophages 	  
 * indicates significant difference between two groups. Number of * represents p-value summary. “NS” indicates no significant difference.  
Among the infectious cases, MDC distinguishes viral from non-viral infectious-type 
processes.  
CONCLUSIONS 
We used  PCA to visually represent the underlying structure of our 
data and examine the variability of specific cytokines/chemokines to help 
distinguish among CNS disease states (non-infectious and infectious, as 
well as viral versus non-viral infections). 
Four weeks following admission, admission CSF was positive 
for human parechovirus (HPeV). 
 
MCP1: 5678.88 pg/ml 
IP10: 23247.43 pg/ml 
MDC: 46.99 pg/ml 
FLT3L: 69.63 pg/ml 
Fractalkine: 100.63 pg/ml 
 
The cytokine profile 
supports infectious, viral-
type etiology. 
